Loading...

Efficacy of Omalizumab in Indolent Systemic Mastocytosis

BACKGROUND: Systemic mastocytosis (SM) comprises a heterogeneous group of disorders characterized by the proliferation of clonal mast cells in skin and various internal organs. Omalizumab is an established, labelled therapy for allergic asthma and chronic urticaria, but its experience in the efficac...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Case Rep Hematol
Main Authors: Slapnicar, Calum, Trinkaus, Martina, Hicks, Lisa, Vadas, Peter
Format: Artigo
Sprog:Inglês
Udgivet: Hindawi 2019
Fag:
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6766258/
https://ncbi.nlm.nih.gov/pubmed/31637065
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2019/3787586
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!